LPL Financial
COGT icon

LPL Financial’s Cogent Biosciences COGT Stock Holding History

LPL Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Sell
74,155
-50,083
-40% -$1.85M ﹤0.01% 3170
2025
Q4 		$4.41M Buy
124,238
+74,036
+147% +$2.08M ﹤0.01% 2640
2025
Q3 		$721K Buy
50,202
+31,199
+164% +$370K ﹤0.01% 4318
2025
Q2 		$136K Hold
19,003
– – ﹤0.01% 5194
2025
Q1 		$114K Buy
+19,003
New +$149K ﹤0.01% 5010
2023
Q1 		– Sell
-14,774
Closed -$171K – 4501
2022
Q4 		$171K Sell
14,774
-1,500
-9% -$18.6K ﹤0.01% 4030
2022
Q3 		$243K Buy
+16,274
New +$223K ﹤0.01% 3764
2021
Q3 		– Sell
-15,000
Closed -$122K – 4340
2021
Q2 		$122K Buy
15,000
+4,000
+36% +$33.8K ﹤0.01% 4022
2021
Q1 		$97K Buy
+11,000
New +$106K ﹤0.01% 3931

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

LPL Financial's COGT Position: Q1 2026 in Review

LPL Financial reduced its Cogent Biosciences (COGT) stake by 40% in Q1 2026, selling an estimated $1.85M and leaving 74,155 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3170.

LPL Financial first reported a position in COGT in Q1 2021 and has held it in 9 quarters since. The position peaked at $4.41M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • LPL Financial held 74,155 shares of Cogent Biosciences worth $2.85M as of Q1 2026.
  • LPL Financial sold 50,083 Cogent Biosciences shares in Q1 2026, an estimated $1.85M.
  • Cogent Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #3170 holding.
  • LPL Financial first reported a position in Cogent Biosciences in Q1 2021 and has held it in 9 quarters since.
  • LPL Financial's Cogent Biosciences position peaked at $4.41M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.